Abstract: Apparatuses, methods, and systems for detecting changes in customer behavior are disclosed. One method includes detecting customer action data, receiving, by a marketing platform server, the customer action data over a period of time, determining, customer parameters including a mean, and a standard deviation of the customer action data, generating a normalization value when the standard deviation is detected to be less than a deviation threshold, calculating, by the marketing platform server, a value of deviation from expectation based at least on the mean, the normalization value, and a noise factor, calculating a current cumulative sum value of the customer action data based on a prior cumulative sum value and the value of the deviation from expectation, comparing the current cumulative sum value with a threshold, and generating an electronic communication for the merchant server when the current cumulative sum value satisfies a compared condition with the preselected threshold.

Abstract: Apparatuses, methods, and systems for detecting changes in customer behavior are disclosed. One method includes detecting customer action data, receiving, by a marketing platform server, the customer action data over a period of time, determining, customer parameters including a mean, and a standard deviation of the customer action data, generating a normalization value when the standard deviation is detected to be less than a deviation threshold, calculating, by the marketing platform server, a value of deviation from expectation based at least on the mean, the normalization value, and a noise factor, calculating a current cumulative sum value of the customer action data based on a prior cumulative sum value and the value of the deviation from expectation, comparing the current cumulative sum value with a threshold, and generating an electronic communication for the merchant server when the current cumulative sum value satisfies a compared condition with the preselected threshold.

Abstract: Apparatuses, methods, and systems for detecting changes in periodic sub-user behavior data for determining a condition of a network are disclosed. One method includes sensing the user data of sub-users, calculating a plurality of thresholds based on a size of the user data, calculating a rolling mean for each sub-period of a larger period, generating difference values based on comparing current sub-period values to corresponding sub-period rolling mean, accumulating a cumulative sum based the difference values, detecting an anomaly based on comparing the cumulative sum with the plurality of thresholds, detecting a condition of a state of communication between the user server and the platform server when the comparing of the cumulative sum with the plurality of threshold exceeds a condition detection threshold, and feeding the condition of the state of communication back to the user server when the condition is detected.

Abstract: Apparatuses, methods, and systems for generating short messages for electronic messages of electronic marketing messages. One method includes receiving, by a server, information related to the electronic marketing message, receiving, by the server, a plurality of N short messages (text) generated based on the received information from a generative text engine model, reducing, by the server, the plurality of N short messages down to M short messages, displaying messages based on the M short messages to a merchant user, identifying merchant actions in response to the displaying of the messages based on the M short messages, and fine-tuning, by the server, the generative text engine model based on the identified merchant actions.

Abstract: The present disclosure relates generally to bilayer tablets comprising a combination of two active pharmaceutical ingredients, and more specifically to bilayer tablets comprising acetylsalicylic acid, pseudoephedrine, and a dissolution aid. The bilayer tablets utilize a combination of granulated and non-granulated acetylsalicylic acid along with a unique distribution of sodium carbonate as a dissolution aid that provide acetylsalicylic acid and pseudoephedrine in a single dosage form having rapid dissolution and long-term storage stability (low degradation). The present disclosure also provides methods of preparing and of using the bilayer tablets.

Abstract: Apparatuses, methods, and systems for generating short messages for electronic messages of electronic marketing messages. One method includes receiving, by a server, information related to the electronic marketing message, receiving, by the server, a plurality of N short messages (text) generated based on the received information from a generative text engine model, reducing, by the server, the plurality of N short messages down to M short messages, displaying messages based on the M short messages to a merchant user, identifying merchant actions in response to the displaying of the messages based on the M short messages, and fine-tuning, by the server, the generative text engine model based on the identified merchant actions.

Abstract: A modified release benzonatate solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: The present disclosure relates generally to bilayer tablets comprising a combination of two active pharmaceutical ingredients, and more specifically to bilayer tablets comprising acetylsalicylic acid, pseudoephedrine, and a dissolution aid. The bilayer tablets utilize a combination of granulated and non-granulated acetylsalicylic acid along with a unique distribution of sodium carbonate as a dissolution aid that provide acetylsalicylic acid and pseudoephedrine in a single dosage form having rapid dissolution and long-term storage stability (low degradation). The present disclosure also provides methods of preparing and of using the bilayer tablets.

Abstract: Apparatuses, methods, and systems for detecting changes in customer behavior are disclosed. One method includes detecting customer action data, receiving, by a marketing platform server, the customer action data over a period of time, determining, customer parameters including a mean, and a standard deviation of the customer action data, generating a normalization value when the standard deviation is detected to be less than a deviation threshold, calculating, by the marketing platform server, a value of deviation from expectation based at least on the mean, the normalization value, and a noise factor, calculating a current cumulative sum value of the customer action data based on a prior cumulative sum value and the value of the deviation from expectation, comparing the current cumulative sum value with a threshold, and generating an electronic communication for the merchant server when the current cumulative sum value satisfies a compared condition with the preselected threshold.

Abstract: Apparatuses, methods, and systems for detecting changes in customer behavior are disclosed. One method includes detecting customer action data, receiving the customer action data over a period of time, determining customer parameters including a mean, and a standard deviation of the customer action data, determining a modified noise factor based on the value of the customer action data, to make the change detection system more sensitive to certain values, calculating a value of deviation from expectation based at least on the mean, the standard deviation, and the modified noise factor, calculating a current cumulative sum value of the customer action data based on a prior cumulative sum value and the value of the deviation from expectation, comparing the current cumulative sum value with a preselected threshold, and generating an informative electronic communication when the current cumulative sum value satisfies a compared condition with the preselected threshold.

Abstract: A modified release benzonatate solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: The present disclosure relates generally to bilayer tablets comprising a combination of two active pharmaceutical ingredients, and more specifically to bilayer tablets comprising acetylsalicylic acid, pseudoephedrine, and a dissolution aid. The bilayer tablets utilize a combination of granulated and non-granulated acetylsalicylic acid along with a unique distribution of sodium carbonate as a dissolution aid that provide acetylsalicylic acid and pseudoephedrine in a single dosage form having rapid dissolution and long-term storage stability (low degradation). The present disclosure also provides methods of preparing and of using the bilayer tablets.

Abstract: A modified release benzonatate solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: A modified release benzonatate solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: Systems and methods are described for managing conflicts between a load balancing protocol and a neighbor relations protocol. Network characteristics for an access node in communication with a plurality of wireless devices may be determined. The plurality of wireless devices may be classified into a high priority class and a low priority class based on a traffic requirement for each of the wireless devices. The determined network conditions my then be compared to a criteria. Based on the comparison, the high priority class of wireless devices may be instructed to perform one of a neighbor relations protocol and a load balancing protocol.

Abstract: A modified release benzonatate solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.

Abstract: A 12-hour anti-tussive modified release solid tablet or capsule is described which comprises a benzonatate adsorbate in a matrix with a sufficient amount of one or more pharmaceutically acceptable modified release pH-independent, substances to provide a 12-hour modified release profile to the benzonatate, wherein there is substantially no benzonatate release from the tablet or capsule in the buccal cavity and no more than about 25% release of the benzonatate within 1 hour as determined in an in vitro dissolution assay.